Aripiprazole and neuroleptic malignant syndrome

J Clin Psychopharmacol. 2007 Apr;27(2):212-4. doi: 10.1097/01.jcp.0000264967.62334.bc.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole
  • Humans
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / etiology*
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Psychotic Disorders / drug therapy
  • Quinolones / adverse effects*
  • Quinolones / therapeutic use

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole